EUVIMEDEUVIMED entdecken
Validierungsstudie

Prospective validation of a machine learning model for applicator and hybrid interstitial needle selection in high-dose-rate (HDR) cervical brachytherapy

Kailyn Stenhouse, Michael Roumeliotis, Philip Ciunkiewicz, Kevin Martell, Sarah Quirk, Robyn Banerjee, Corinne Doll, Tien Phan, Svetlana Yanushkevich, Philip McGeachy

Brachytherapy · 2024

DOI: 10.1016/j.brachy.2024.02.008 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Brachytherapy, 2024. Verfasst von Kailyn Stenhouse und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada; Department of Medical Physics, Tom Baker Cancer Centre, Calgary…. Hauptthemen laut MEDLINE: Brachytherapy, Uterine Cervical Neoplasms, Machine Learning, Radiotherapy Dosage. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Alberta Innovates, University of Calgary, Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To Demonstrate the clinical validation of a machine learning (ML) model for applicator and interstitial needle prediction in gynecologic brachytherapy through a prospective clinical study in a single institution. METHODS: The study included cervical cancer patients receiving high-dose-rate brachytherapy using intracavitary (IC) or hybrid interstitial (IC/IS) applicators. For each patient, the primary radiation oncologist contoured the high-risk clinical target volume on a pre-brachytherapy MRI, indicated the approximate applicator location, and made a clinical determination of the first fraction applicator. A pre-trained ML model predicted the applicator and IC/IS needle arrangement using tumor geometry. Following the first fraction, ML and radiation oncologist predictions were compared and a replanning study determined the applicator providing optimal organ-at-risk (OAR) dosimetry. The ML-predicted applicator and needle arrangement and the clinical determination were compared to this dosimetric ground truth. RESULTS: Ten patients were accrued from December 2020 to October 2022. Compared to the dosimetrically optimal applicator, both the radiation oncologist and ML had an accuracy of 70%. ML demonstrated better identification of patients requiring IC/IS applicators and provided balanced IC and IC/IS predictions. The needle selection model achieved an average accuracy of 82.5%. ML-predicted needle arrangements matched or improved plan quality when compared to clinically selected arrangements. Overall, ML predictions led to an average total improvement of 2.0 Gy to OAR doses over three treatment fractions when compared to clinical predictions. CONCLUSION: In the context of a single institution study, the presented ML model demonstrates valuable decision-support for the applicator and needle selection process with the potential to provide improved dosimetry. Future work will include a multi-center study to assess generalizability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyUterine Cervical NeoplasmsMachine LearningRadiotherapy DosageHumansFemaleProspective StudiesNeedlesRadiotherapy Planning, Computer-AssistedMiddle AgedOrgans at RiskAged

Stichwörter der Autor:innen

Cervical brachytherapyHigh-dose-rate brachytherapyMachine learningValidation study

Autor:innen und Institutionen

  • Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada; Department of Medical Physics, Tom Baker Cancer Centre, Calgary, Alberta, Canada. Electronic address: kjstenho@ucalgary.ca.
  • Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, MD. Electronic address: mroum…
  • Department of Biomedical Engineering, University of Calgary, Calgary, Alberta, Canada.
  • Department of Oncology, University of Calgary, Calgary, Alberta, Canada.
  • Department of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA.
  • Department of Electrical and Computer Engineering, University of Calgary, Calgary, Alberta, Canada.

Förderung

  • Alberta Innovates
  • University of Calgary
  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Stenhouse, K., Roumeliotis, M., Ciunkiewicz, P., Martell, K., Quirk, S., Banerjee, R., Doll, C., Phan, T., Yanushkevich, S., & McGeachy, P. (2024). Prospective validation of a machine learning model for applicator and hybrid interstitial needle selection in high-dose-rate (HDR) cervical brachytherapy. Brachytherapy. https://doi.org/10.1016/j.brachy.2024.02.008

Vancouver

Stenhouse K, Roumeliotis M, Ciunkiewicz P, Martell K, Quirk S, Banerjee R, et al. Prospective validation of a machine learning model for applicator and hybrid interstitial needle selection in high-dose-rate (HDR) cervical brachytherapy. Brachytherapy. 2024. doi:10.1016/j.brachy.2024.02.008

BibTeX
@article{Stenhouse2024,
  author = {Stenhouse, Kailyn and Roumeliotis, Michael and Ciunkiewicz, Philip and Martell, Kevin and Quirk, Sarah and Banerjee, Robyn and Doll, Corinne and Phan, Tien and Yanushkevich, Svetlana and McGeachy, Philip},
  title = {Prospective validation of a machine learning model for applicator and hybrid interstitial needle selection in high-dose-rate (HDR) cervical brachytherapy},
  journal = {Brachytherapy},
  year = {2024},
  doi = {10.1016/j.brachy.2024.02.008}
}
Kostenlos starten →